What is Gland Pharma Ltd. Quarterly Revenue?

Gland Pharma Ltd. Quarterly Revenue Gland Pharma Jun-2026 Quarterly Revenue is Rs 1,345 Cr which is growth of 23.0% YoY.

What is Gland Pharma Ltd. Quarterly Net Profit?

Gland Pharma Ltd. Quarterly Net Profit Gland Pharma Jun-2026 Quarterly Net Profit is Rs 364 Cr which is growth of 35.3% YoY.

What is Gland Pharma Ltd. Annual Revenue?

Gland Pharma Ltd. Annual Revenue Gland Pharma Mar-2026 Annual Revenue is Rs 4,856 Cr which is growth of 12.1% YoY.

What is Gland Pharma Ltd. Annual Net Profit?

Gland Pharma Ltd. Annual Net Profit Gland Pharma Mar-2026 Annual Net Profit is Rs 1,300 Cr which is growth of 19.3% YoY.

What is Gland Pharma Ltd. Total Shareholders Fund?

Gland Pharma Ltd. Total Shareholders Fund Gland Pharma Mar-2026 Total Shareholders Fund is Rs 10,810 Cr which is growth of 10.8% YoY.

What is Gland Pharma Ltd. Total Assets?

Gland Pharma Ltd. Total Assets Gland Pharma Mar-2026 Total Assets is Rs 11,607 Cr which is growth of 11.4% YoY.

What is Gland Pharma Ltd. Book Value Per Share?

Gland Pharma Ltd. Book Value Per Share Gland Pharma Mar-2026 Book Value Per Share is 656 Rs which is growth of 10.8% YoY.

What is Gland Pharma Ltd. ROE?

Gland Pharma Ltd. ROE Gland Pharma Mar-2026 ROE is 12% which is growth of 0.8% YoY.

What is Gland Pharma Ltd. Cash From Operating Activity?

Gland Pharma Ltd. Cash From Operating Activity Gland Pharma Mar-2026 Cash From Operating Activity is Rs 1,135 Cr which is growth of 5.7% YoY.

What is Gland Pharma Ltd. Net Cash Flow?

Gland Pharma Ltd. Net Cash Flow Gland Pharma Mar-2026 Net Cash Flow is Rs 723 Cr which is growth of -68.7% YoY.

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245

Strong Performer, Getting Expensive

Download real time

US FDA Inspections ANDA Approvals

-29.30(-0.95%)

Near 52W High of ₹3171.00

286.4K

NSE+BSE Volume

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Gland Pharma is on 06 Nov 2026 for the purpose of Quarterly Results See details

Gland Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Gland Pharma share price target, revenues, EPS, net income and more

Gland Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Gland Pharma Jun-2026 Quarterly Revenue is Rs 1,345 Cr which is growth of 23.0% YoY.
POSITIVE
Quarterly Net Profit Gland Pharma Jun-2026 Quarterly Net Profit is Rs 364 Cr which is growth of 35.3% YoY.

Gland Pharma Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	1,345.5	1,368	1,237.7	1,156.7	1,093.6	1,074.1	1,075.9	1,120.8	1,060.5	1,221.8	1,141.3	1,051.8	919.3
SR_Q Operating Rev.	1,286.6	1,261.6	1,177.5	1,074.2	1,038.8	1,030.4	1,010.8	1,063	1,012	1,174.8	1,097.9	1,010.7	884.1
OI_Q Other Income	58.8	106.4	60.2	82.6	54.7	43.7	65.1	57.8	48.5	47	43.4	41.1	35.2
OEXPNS_Q Operating Exp.	813.1	753.9	755.9	699.3	680	636.2	619.6	699.2	718.5	742	728.4	663.6	624.7
OEXPNS_Q Operating Exp.	813.1	753.9	755.9	699.3	680	636.2	619.6	699.2	718.5	742	728.4	663.6	624.7
OP_Q Operating Profit	473.5	507.7	421.6	374.9	358.8	394.1	391.1	363.8	293.6	432.8	369.5	347.1	259.4
OPMPCT_Q Operating Profit Margin %	36.80%	40.24%	35.81%	34.90%	34.54%	38.25%	38.70%	34.22%	29.01%	36.84%	33.66%	34.34%	29.34%
DEP_Q Depr.	44	43.1	44.5	44.8	43.8	43.1	43.8	41.6	40.8	42.6	40.3	40.2	39
INT_Q Interest	0.7	6.2	0.5	4	7.4	3.5	18.3	0.2	0.9	4.5	0.8	0.9	1.6
PBT_Q Profit Before Tax	487.7	564.8	412.5	408.7	362.4	391.3	394.1	379.8	300.3	432.7	371.8	347.1	254
TAX_Q Tax	123.3	144.4	104.6	106.7	93.1	101.3	99	98.1	77.4	111.3	95	89.5	66.4
NP_Q Net Profit	364.4	420.5	307.9	302	269.3	290	295.1	281.7	222.9	321.4	276.8	257.5	187.6
EPS_adj_Q EPS Adj. latest	22.1	25.5	18.7	18.3	16.3	17.6	17.9	17.1	13.5	19.5	16.8	15.6	11.4
NP_TTM Net profit TTM	1,394.7	1,299.6	1,169.1	1,156.4	1,136.1	1,089.8	1,121.2	1,102.9	1,078.7	1,043.3	801.1	751.9	734
EPS_TTM Basic EPS TTM	84.6	78.9	71	70.2	69	66.1	68.1	66.9	65.5	63.3	48.6	45.7	44.6
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Gland Pharma competitor comparison and performance snapshot within industry

Gland Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Gland Pharma Mar-2026 Annual Revenue is Rs 4,856 Cr which is growth of 12.1% YoY.
POSITIVE
Annual Net Profit Gland Pharma Mar-2026 Annual Net Profit is Rs 1,300 Cr which is growth of 19.3% YoY.

Gland Pharma Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
SR_A Total Rev. Ann. ⌄	8%	6.2%	5,107.9	4,856	4,331.2	4,334.1	3,857	4,624.7	3,597.7	2,772.4	2,129.8	1,668.7	1,512.7
TotalOperatingRevenues_A Operating Rev. Ann.	8%	5.6%	4,799.9	4,552.1	4,116.2	4,167.4	3,616.5	4,400.7	3,462.9	2,633.2	2,044.2	1,619.9	1,479.2
OI_A Other Income Ann.	8.1%	17.7%	308	303.9	215.1	166.7	240.5	223.9	134.8	139.2	85.6	48.8	33.6
OEXPNS_A Operating Exp. Ann.	3.6%	6%	3,022.2	2,889	2,673.5	2,758.7	2,598	2,890.1	2,160.6	1,677.8	1,337.9	1,084.8	854.2
OEXPNS_A Operating Exp. Ann.	3.6%	6%	3,022.2	2,889	2,673.5	2,758.7	2,598	2,890.1	2,160.6	1,677.8	1,337.9	1,084.8	854.2
OP_A Operating Profit Ann.	17.8%	5%	1,777.7	1,663.1	1,442.6	1,408.8	1,018.6	1,510.6	1,302.3	955.5	706.3	535.1	625
OPMPCT_A OPM Ann. %	9.1%	-1.1%		34.25%	33.31%	32.50%	26.41%	32.66%	36.20%	34.46%	33.16%	32.07%	41.32%
TotalExpenses_A Total Exp. Ann. ⌄	3.9%	6.4%		3,083.3	2,865.6	2,928.6	2,752.1	3,005.6	2,262.8	1,779.5	1,423.4	1,167.2	934.7
OtherExpenses_A Other Exp. Ann.	4.5%	9.4%	476.1	442.7	383.5	411.2	388	347.2	282.8	219.6	183.9	184.7	141.8
EmployeeBenefitExpenses_A Employee Exp. Ann.	9.8%	11.2%	544.3	528.8	439	409.9	399.7	338.6	311.4	277.7	223	179.1	153.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-	125.9
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	16%	6.5%		1,967	1,657.7	1,575.5	1,259	1,734.6	1,437	1,094.6	791.9	583.9	658.6
EBIDTPCT_A EBITDA Ann. margin %	7.5%	0.3%		40.51%	38.27%	36.35%	32.64%	37.51%	39.94%	39.48%	37.18%	34.99%	43.53%
INT_A Interest Ann.	34.7%	39.7%	11.3	18.1	22.8	7.8	7.4	5.2	3.4	7.2	3.6	4.1	6.4
DEP_A Depr.	6.3%	12.3%	176.4	176.2	169.3	162.1	146.7	110.3	98.8	94.6	82	78.2	74.2
PBT_A PBT Ann.	18.6%	5.5%	1,873.6	1,748.3	1,465.6	1,405.5	1,048.4	1,619	1,334.9	992.9	686.4	501.6	578
TAX_A Tax Ann.	18.1%	5.8%	478.9	448.8	375.8	362.2	272.6	406.9	337.9	220	234.5	180.5	164.3
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	18.8%	5.4%		1,299.6	1,089.8	1,043.3	775.8	1,212.2	997	772.9	451.9	321.1	413.7
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	18.8%	5.4%	1,394.7	1,299.6	1,089.8	1,043.3	775.8	1,212.2	997	772.9	451.9	321.1	413.7
NETPCT_A NPM Ann. %	10%	-0.2%		28.54%	26.47%	25.03%	21.45%	27.54%	28.79%	29.35%	22.10%	19.82%	27.97%
EPS_adj_A EPS Adj. latest Ann.	18.8%	5.5%		78.8	66	63.2	47	73.5	60.4	46.8	27.4	19.5	25.1
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

12.1%

2Y CAGR

5.8%

3Y CAGR

5Y CAGR

6.2%

7Y CAGR

12.5%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

19.3%

2Y CAGR

11.6%

3Y CAGR

18.8%

5Y CAGR

5.4%

7Y CAGR

16.3%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

8.1%

2Y CAGR

2.3%

3Y CAGR

3.6%

5Y CAGR

7Y CAGR

11.6%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Gland Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Gland Pharma Mar-2026 Total Shareholders Fund is Rs 10,810 Cr which is growth of 10.8% YoY.
POSITIVE
Total Assets Gland Pharma Mar-2026 Total Assets is Rs 11,607 Cr which is growth of 11.4% YoY.

Gland Pharma Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	10.8%	12.9%	10,810	9,755.1	8,995.3	7,953.3	7,158.2	5,903.3	3,646.2	2,862.1	2,410.4	2,089.8
EQCAP_A Equity Share Capital Ann.	0%	0.1%	16.5	16.5	16.5	16.5	16.4	16.4	15.5	15.5	15.5	15.5
TotalShareCapital_A Total Share Capital Ann.	0%	0.1%	16.5	16.5	16.5	16.5	16.4	16.4	15.5	15.5	15.5	15.5
ReservesAndSurplus_A Reserves Plus Surplus Ann.	10.8%	12.9%	10,793.6	9,738.6	8,977.4	7,935.2	7,141.7	5,886.9	3,630.7	2,846.6	2,394.9	2,074.3
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	10.8%	12.9%	10,793.6	9,738.6	8,977.4	7,935.2	7,141.7	5,886.9	3,630.7	2,846.6	2,394.9	2,074.3
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	22.3%	15.4%	164.2	142.8	131.6	89.7	94	80.3	80.8	127.8	139.4	130.6
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	10.9%	9.2%	114.8	116.4	108.3	84.2	87.8	73.9	74.1	107.6	95.8	85.4
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	4.4%	0%	2.5	2.4	0.1	2.2	2.4	2.5	2.7	15.2	38.1	39.3
CL_A Total Current Liabilities Ann. ⌄	-4.7%	4.3%	633	523.8	414.2	730.2	581.9	512.5	359	532.7	378.6	253.4
TradePayables_A Trade Payables Ann.	-6.3%	3.9%	485.4	385.9	295.1	589.4	462.8	400.7	249.1	446.2	292.4	189.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	8.8%	10.1%	140.3	130.7	112.7	108.9	94.3	86.7	92.5	83.6	84	61.9
ShortTermProvisions_A ST Provisions Ann.	-38.2%	-21.7%	7.4	5.7	5.7	31.3	24.8	25.1	17.5	2.9	2.1	2.2
TL_A Total Capital Plus Liabilities Ann.	9.8%	12.3%	11,607.2	10,421.6	9,541.1	8,773.2	7,834.1	6,496.1	4,086	3,522.6	2,928.3	2,473.7
FixedAssets_A Fixed Assets Ann. ⌄	1.5%	7.2%	1,826.1	1,787.2	1,813.7	1,747.8	1,692.9	1,292	1,156.6	1,051.9	1,041.5	1,032.7
TangibleAssets_A Tangible Assets Ann.	2.7%	12.1%	1,686.4	1,738.5	1,682.7	1,558.9	1,499.7	954.2	968.1	928.7	842.6	871.6
IntangibleAssets_A Intangible Assets Ann.	-44.5%	-	2	6.5	11.1	11.7	2.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	-8.1%	-16.4%	137.6	42.2	120	177.2	180.7	337.8	188.5	123.2	198.9	161.2
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	40.1%	30.4%	5,185	4,654.7	4,969.8	1,884.8	1,989.7	1,373	1,239.8	1,165.1	1,077.4	1,065.6
NonCurrentInvestments_A Non Current Investments Ann.	637.7%	459.6%	3,292.6	2,789.6	2,385.7	8.2	8.2	0.6
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-									5.9	5.6
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-19.8%	-3.8%	66.4	77.9	770.3	128.9	288.6	80.4	83.2	113.2	30	27.3
CA_A Total Current Assets Ann. ⌄	-2.3%	4.6%	6,422.2	5,767	4,571.3	6,888.3	5,844.4	5,123.1	2,846.3	2,357.5	1,851	1,408.2
CurrentInvestments_A Current Investments Ann.	-	-					154.9
TradeReceivables_A Trade Receivables Ann.	20.8%	17.8%	1,520.7	1,142.9	1,171.4	862.8	1,198.8	671	601.8	506.1	475.2	417.9
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-5.5%	1.1%	3,177.6	2,432.6	1,598.6	3,767	3,085.8	3,005.2	1,325.2	753.4	670.8	533.1
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-				0.1	0.5	0.3	0.5	0.3	0.5	0.4
OtherCurrentAssets_A Other Current Assets Ann.	13.6%	21.7%	458.7	937.2	541.2	313.1	218.9	171.5	162.5	185.9	191.6	78.1
TA_A Total Assets Ann.	9.8%	12.3%	11,607.2	10,421.6	9,541.1	8,773.2	7,834.1	6,496.1	4,086	3,522.6	2,928.3	2,473.7
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	18.2%	-0.6%	212.3	114.7	100.7	128.5	124.5	219.2	134.5	171.6	51.2	103.7
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	3,292.6	2,789.6	2,385.7
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

11.4%

2Y CAGR

10.3%

3Y CAGR

9.8%

5Y CAGR

12.3%

7Y CAGR

18.6%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

20.8%

2Y CAGR

23.6%

3Y CAGR

-4.7%

5Y CAGR

4.3%

7Y CAGR

2.5%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

10.8%

2Y CAGR

9.6%

3Y CAGR

10.8%

5Y CAGR

12.9%

7Y CAGR

20.9%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Gland Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Gland Pharma Mar-2026 Book Value Per Share is 656 Rs which is growth of 10.8% YoY.
POSITIVE
ROE Gland Pharma Mar-2026 ROE is 12% which is growth of 0.8% YoY.

Gland Pharma Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
BVSH_A BVSH Ann.	10.8%	12.7%	656.1	592.1	546.1	482.9	435.7	360.9	235.3	1,847.1	1,555.6	1,348.7
ROA_A RoA Ann. %	8.2%	-6.1%	11.19%	10.45%	10.93%	8.84%	15.47%	15.34%	18.91%	12.82%	10.96%	16.72%
ROE_A ROE Ann. %	7.2%	-6.6%	12.02%	11.17%	11.59%	9.75%	16.93%	16.88%	21.19%	15.78%	13.32%	19.79%
ROCE_A ROCE Ann. %	5.7%	-6.1%	16.31%	15.03%	15.48%	13.82%	22.39%	22.36%	26.83%	23.74%	19.83%	26.32%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	7.5%	0.8%	43.21%	40.27%	37.80%	34.81%	39.41%	41.49%	41.56%	38.73%	36.04%	44.52%
PBITMargin_A EBIT Ann. Margin %	8.5%	0.4%	39.33%	36.16%	33.91%	30.75%	36.90%	38.64%	37.97%	34.72%	31.21%	39.50%
PBTMargin_A PBT Ann. Margin %	9.8%	-0.1%	38.40%	35.60%	33.72%	28.98%	36.79%	38.54%	37.70%	33.57%	30.96%	39.07%
NETPCT_A NPM Ann. %	10%	-0.2%	28.54%	26.47%	25.03%	21.45%	27.54%	28.79%	29.35%	22.10%	19.82%	27.97%
ASETTO_A Asset Turnover Ann. %	0%	-10.6%	0.4	0.4	0.5	0.4	0.6	0.7	0.7	0.6	0.6	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	2.8%	0.4%	10.2	11	11	9.4	10	10	7.9	4.4	4.9	5.6
QuickRatio_A Quick Ratio Ann.	6.4%	1.8%	8.2	8.6	8	6.8	8	7.5	5.8	2.7	3.5	4.1
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0.2	0.3					-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-	77.18%	69.77%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	79.91%	73.83%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	79.91%	73.83%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	13.1%	-8%	24,787.1	23,803	28,742.7	17,130.7	50,630.3	37,533.1
EVPerNetSales_A EV Per Net Sales Ann.	5.4%	-12.6%	5.5	5.8	6.9	4.7	11.5	10.8	-	-	-	-
PBV_A Price To Book Value Adjusted	-9.7%	-11.3%	4.68	5.51	5.62	6.35	7.04	8.5	13.03	1.66	1.97	2.27
EVPerEBITDA_A EV Per EBITDA Ann.	-2.5%	-13.6%	12.6	14.4	18.2	13.6	29.2	26.1	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	1.7%	-12.2%	6.1	6.4	7.3	5.8	12.2	11.7	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-	77.17%	69.76%
EYield_A Earnings Yield Ann.	-	-	0.1	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

7.6%

2Y CAGR

1.8%

3Y CAGR

7.2%

5Y CAGR

-6.6%

7Y CAGR

-3.8%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

7.1%

2Y CAGR

1.2%

3Y CAGR

8.2%

5Y CAGR

-6.1%

7Y CAGR

-1.9%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

-7.3%

2Y CAGR

-3.7%

3Y CAGR

2.8%

5Y CAGR

0.4%

7Y CAGR

12.8%

Current Ratio Annual is falling faster than historical averages.

Gland Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Gland Pharma Mar-2026 Cash From Operating Activity is Rs 1,135 Cr which is growth of 5.7% YoY.
NEGATIVE
Net Cash Flow Gland Pharma Mar-2026 Net Cash Flow is Rs 723 Cr which is growth of -68.7% YoY.

Gland Pharma Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17
CFO_A Cash from Operating Act. Ann. ⌄	45.6%	13.4%	1,135.2	1,073.7	1,136	367.9	791.3	604.9	700.9	185.1	201.9	476.5
PBT_A PBT Ann.	18.6%	5.5%	1,748.3	1,465.6	1,405.5	1,048.4	1,619	1,334.9	992.9	686.4	501.6	578
INT_A Interest Ann.	34.7%	39.7%	18.1	22.8	7.8	7.4	5.2	3.4	7.2	3.6	4.1	6.4
TAX_A Tax Ann.	18.1%	5.8%	448.8	375.8	362.2	272.6	406.9	337.9	220	234.5	180.5	164.3
CFI_A Cash from Investing Act. Ann.	-	-	-95.6	1,578.2	-2,923.9	1,208.2	-1,010.2	-1,524.6	-766.1	-314.1	-358.8	-96.7
CFA_A Cash from Financing Act. Ann.	-	-	-316.2	-339.5	-7.4	14.9	34.9	1,238.5	-6.9	-2.9	-3.6	-116.4
NCF_A Net Cash Flow Ann. ⌄	-23.1%	17.8%	723.5	2,312.3	-1,795.4	1,591	-184	318.8	-72	-132	-160.5	263.4
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	98.5%	70.4%	2,432.6	116.2	1,905.2	311.2	491.9	169.5	236.4	372.8	533.1	273.2
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	18.6%	45.2%	3,177.6	2,432.6	116.2	1,905.2	311.2	491.9	169.5	236.4	372.8	533.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

5.7%

2Y CAGR

3Y CAGR

45.6%

5Y CAGR

13.4%

7Y CAGR

29.6%

Cash from Operating Activity Annual growth is lower than historical averages.

Gland Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Gland Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Gland Pharma - Forecaster

Forecaster Analyst Estimates for Gland Pharma share price target, revenues, EPS, net income and more